Emtricitabine 100 MG / tenofovir disoproxil fumarate 150 MG Oral Tablet — RxCUI 1744001
RxNorm drug concept · Semantic clinical drug
RxCUI 1744001
Semantic clinical drug · SCD
● Current RxNorm concept 19 FDA products
35 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1744001
Official nameEmtricitabine 100 MG / tenofovir disoproxil fumarate 150 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asemtricitabine 100 MG / tenofovir disoproxil fumarate 150 MG (equivalent to tenofovir disoproxil 123 MG) Oral Tablet
FDA products mapped19
Package NDCs mapped35
Reported Medicaid activity (SDUD)4,944 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Emtricitabine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Emtricitabine doesn't cure HIV, but it's an important part of keeping the virus under control. It works by blocking an enzyme HIV needs to make copies of itself. When it's used alo...
- What exactly does emtricitabine do — does it cure HIV?
- Please don't stop without talking to your doctor first. If you also have hepatitis B, stopping emtricitabine can trigger a sudden, severe flare of hepatitis B — sometimes serious e...
- Can I stop taking emtricitabine if I feel fine or if I also have hepatitis B?
🕸️ Concept Web — How Emtricitabine 100 MG / tenofovir disoproxil fuma... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Emtricitabine 100 MG / tenofovir disoproxil fumarate 150 MG Oral Tablet
RxCUI 1744001 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Emtricitabine
276237IN -
Tenofovir disoproxil
300195IN -
Emtricitabine / tenofovir disoproxil
1008145MIN -
Tenofovir disoproxil fumarate
322248PIN
-
Emtricitabine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Truvada
495430BN
-
Truvada
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Emtricitabine / tenofovir disoproxil Oral Tablet
540395SCDF -
Emtricitabine / tenofovir disoproxil fumarate Oral Tablet
2646946SCDFP -
Emtricitabine / tenofovir disoproxil Oral Product
1161885SCDG -
Emtricitabine / tenofovir disoproxil Pill
1161886SCDG -
Emtricitabine / tenofovir disoproxil fumarate Oral Product
2660775SCDGP -
Emtricitabine / tenofovir disoproxil fumarate Pill
2663633SCDGP -
Emtricitabine / tenofovir disoproxil Oral Tablet [Truvada]
540398SBDF -
Emtricitabine / tenofovir disoproxil fumarate Oral Tablet [Truvada]
2657350SBDFP - +5 more in this family
-
Emtricitabine / tenofovir disoproxil Oral Tablet
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Emtricitabine 100 MG
1744000SCDC -
Tenofovir disoproxil fumarate 150 MG
1243323SCDC -
Emtricitabine 100 MG / tenofovir disoproxil fumarate 150 MG Oral Tablet [Truvada]
1744003SBD -
Emtricitabine 100 MG / tenofovir disoproxil fumarate 150 MG [Truvada]
1744002SBDC
-
Emtricitabine 100 MG
Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Emtricitabine 100 MG
SCDC · 1744000 -
Tenofovir disoproxil fumarate 150 MG
SCDC · 1243323 -
Emtricitabine / tenofovir disoproxil Oral Tablet
SCDF · 540395 -
Emtricitabine / tenofovir disoproxil fumarate Oral Tablet
SCDFP · 2646946 -
Emtricitabine / tenofovir disoproxil Oral Product
SCDG · 1161885 -
Emtricitabine / tenofovir disoproxil Pill
SCDG · 1161886 -
Emtricitabine / tenofovir disoproxil fumarate Oral Product
SCDGP · 2660775 -
Emtricitabine / tenofovir disoproxil fumarate Pill
SCDGP · 2663633
Brand-Name Concepts
-
Emtricitabine 100 MG / tenofovir disoproxil fumarate 150 MG Oral Tablet [Truvada]
SBD · 1744003 -
Emtricitabine 100 MG / tenofovir disoproxil fumarate 150 MG [Truvada]
SBDC · 1744002 -
Emtricitabine / tenofovir disoproxil Oral Tablet [Truvada]
SBDF · 540398 -
Emtricitabine / tenofovir disoproxil fumarate Oral Tablet [Truvada]
SBDFP · 2657350 -
Truvada Oral Product
SBDG · 1185614 -
Truvada Pill
SBDG · 1185615 -
Truvada
BN · 495430
📦 FDA Products & Package NDCs
19 products · 35 package NDCs
35 package NDCs map to RxCUI 1744001 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 59651-0165-30 | 30 TABLET, FILM COATED in 1 BOTTLE (59651-165-30) | Emtricitabine and Tenofovir Disoproxil Fumarate | Aurobindo Pharma Limited | 2023-03-09 |
| 59651-0166-30 | 30 TABLET, FILM COATED in 1 BOTTLE (59651-166-30) | Emtricitabine and Tenofovir Disoproxil Fumarate | Aurobindo Pharma Limited | 2023-03-09 |
| 59651-0167-30 | 30 TABLET, FILM COATED in 1 BOTTLE (59651-167-30) | Emtricitabine and Tenofovir Disoproxil Fumarate | Aurobindo Pharma Limited | 2023-03-09 |
| 61958-0701-01 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-0701-1) | Truvada | Gilead Sciences, Inc | 2004-08-02 |
| 61958-0703-01 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-0703-1) | Truvada | Gilead Sciences, Inc | 2016-03-10 |
| 61958-0704-01 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-0704-1) | Truvada | Gilead Sciences, Inc | 2016-03-10 |
| 61958-0705-01 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-0705-1) | Truvada | Gilead Sciences, Inc | 2016-03-10 |
| 69238-2092-03 | 30 TABLET, FILM COATED in 1 BOTTLE (69238-2092-3) | Emtricitabine and Tenofovir Disoproxil Fumarate | Amneal Pharmaceuticals NY LLC | 2018-08-26 |
| 69238-2093-03 | 30 TABLET, FILM COATED in 1 BOTTLE (69238-2093-3) | Emtricitabine and Tenofovir Disoproxil Fumarate | Amneal Pharmaceuticals NY LLC | 2018-08-26 |
| 69238-2094-03 | 30 TABLET, FILM COATED in 1 BOTTLE (69238-2094-3) | Emtricitabine and Tenofovir Disoproxil Fumarate | Amneal Pharmaceuticals NY LLC | 2018-08-26 |
| 69238-2095-03 | 30 TABLET, FILM COATED in 1 BOTTLE (69238-2095-3) | Emtricitabine and Tenofovir Disoproxil Fumarate | Amneal Pharmaceuticals NY LLC | 2018-08-26 |
| 70710-1364-03 | 30 TABLET, FILM COATED in 1 BOTTLE (70710-1364-3) | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals USA Inc. | 2021-07-01 |
| 70710-1364-04 | 10 BLISTER PACK in 1 CARTON (70710-1364-4) / 10 TABLET, FIL... | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals USA Inc. | 2021-07-01 |
| 70710-1364-09 | 90 TABLET, FILM COATED in 1 BOTTLE (70710-1364-9) | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals USA Inc. | 2021-07-01 |
| 70710-1365-03 | 30 TABLET, FILM COATED in 1 BOTTLE (70710-1365-3) | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals USA Inc. | 2021-07-01 |
| 70710-1365-04 | 10 BLISTER PACK in 1 CARTON (70710-1365-4) / 10 TABLET, FIL... | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals USA Inc. | 2021-07-01 |
| 70710-1365-09 | 90 TABLET, FILM COATED in 1 BOTTLE (70710-1365-9) | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals USA Inc. | 2021-07-01 |
| 70710-1366-03 | 30 TABLET, FILM COATED in 1 BOTTLE (70710-1366-3) | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals USA Inc. | 2021-07-01 |
| 70710-1366-04 | 10 BLISTER PACK in 1 CARTON (70710-1366-4) / 10 TABLET, FIL... | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals USA Inc. | 2021-07-01 |
| 70710-1366-09 | 90 TABLET, FILM COATED in 1 BOTTLE (70710-1366-9) | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals USA Inc. | 2021-07-01 |
| 70710-1367-03 | 30 TABLET, FILM COATED in 1 BOTTLE (70710-1367-3) | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals USA Inc. | 2021-03-24 |
| 70710-1367-04 | 10 BLISTER PACK in 1 CARTON (70710-1367-4) / 10 TABLET, FIL... | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals USA Inc. | 2021-03-24 |
| 70710-1367-09 | 90 TABLET, FILM COATED in 1 BOTTLE (70710-1367-9) | Emtricitabine and tenofovir disoproxil fumarate | Zydus Pharmaceuticals USA Inc. | 2021-03-24 |
| 70771-1620-03 | 30 TABLET, FILM COATED in 1 BOTTLE (70771-1620-3) | Emtricitabine and tenofovir disoproxil fumarate | Zydus Lifesciences Limited | 2021-07-01 |
| 70771-1620-04 | 10 BLISTER PACK in 1 CARTON (70771-1620-4) / 10 TABLET, FIL... | Emtricitabine and tenofovir disoproxil fumarate | Zydus Lifesciences Limited | 2021-07-01 |
| 70771-1620-09 | 90 TABLET, FILM COATED in 1 BOTTLE (70771-1620-9) | Emtricitabine and tenofovir disoproxil fumarate | Zydus Lifesciences Limited | 2021-07-01 |
| 70771-1621-03 | 30 TABLET, FILM COATED in 1 BOTTLE (70771-1621-3) | Emtricitabine and tenofovir disoproxil fumarate | Zydus Lifesciences Limited | 2021-07-01 |
| 70771-1621-04 | 10 BLISTER PACK in 1 CARTON (70771-1621-4) / 10 TABLET, FIL... | Emtricitabine and tenofovir disoproxil fumarate | Zydus Lifesciences Limited | 2021-07-01 |
| 70771-1621-09 | 90 TABLET, FILM COATED in 1 BOTTLE (70771-1621-9) | Emtricitabine and tenofovir disoproxil fumarate | Zydus Lifesciences Limited | 2021-07-01 |
| 70771-1622-03 | 30 TABLET, FILM COATED in 1 BOTTLE (70771-1622-3) | Emtricitabine and tenofovir disoproxil fumarate | Zydus Lifesciences Limited | 2021-07-01 |
| 70771-1622-04 | 10 BLISTER PACK in 1 CARTON (70771-1622-4) / 10 TABLET, FIL... | Emtricitabine and tenofovir disoproxil fumarate | Zydus Lifesciences Limited | 2021-07-01 |
| 70771-1622-09 | 90 TABLET, FILM COATED in 1 BOTTLE (70771-1622-9) | Emtricitabine and tenofovir disoproxil fumarate | Zydus Lifesciences Limited | 2021-07-01 |
| 70771-1709-03 | 30 TABLET, FILM COATED in 1 BOTTLE (70771-1709-3) | Emtricitabine and tenofovir disoproxil fumarate | Zydus Lifesciences Limited | 2021-03-24 |
| 70771-1709-04 | 10 BLISTER PACK in 1 CARTON (70771-1709-4) / 10 TABLET, FIL... | Emtricitabine and tenofovir disoproxil fumarate | Zydus Lifesciences Limited | 2021-03-24 |
| 70771-1709-09 | 90 TABLET, FILM COATED in 1 BOTTLE (70771-1709-9) | Emtricitabine and tenofovir disoproxil fumarate | Zydus Lifesciences Limited | 2021-03-24 |
Observed labelers:
Zydus Lifesciences Limited (12) ·
Zydus Pharmaceuticals USA Inc. (12) ·
Amneal Pharmaceuticals NY LLC (4) ·
Gilead Sciences, Inc (4) ·
Aurobindo Pharma Limited (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.